Back

셀루메드 KOSDAQ

049180

Suggest a tag

Watch

Notes Naver Finance

Meeting voting results

Annual 2026.03.31 Includes rejected resolutions

DART

1 제41기(2025사업연도) 별도 및 연결 재무제표 승인의 건 Rejected
2-1 사외이사 박형섭 선임의 건 Rejected
3 이사 보수한도 승인의 건 Rejected
4 감사 보수한도 승인의 건 Rejected

의결정족수 미달로 인해 모든 상정 안건이 부결되었습니다.

Previous meeting results

Financial indicators

Market cap

840 × 100M KRW

Approx. 840 × 100M KRW excluding treasury shares

PBR

3.30

PER

25.2

ROE

-26.06%

Dividend yield

Debt-to-equity ratio

625.9%

Share price history

Share price

Daily close

Latest close

5-year high

5-year low

Use the period buttons above to adjust the range.

Shareholder distribution

Based on 2026 Semiannual report (2026-06-30)

Controlling shareholders total

42.15%

Minority shareholders (excl. related parties)

55.38%

Large outside holders (1%+)

2.46% (1 people)

Treasury shares

0.01%

Total shareholders

43,699 people

Annual earnings Trend

Financial statements

Consolidated · includes subsidiaries

셀루메드 — Annual Consolidated Financial statements
Item	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Income statement
Revenue	306.7 × 100M KRW	207.3 × 100M KRW	177.3 × 100M KRW	98.1 × 100M KRW	199 × 100M KRW	108.4 × 100M KRW	179.2 × 100M KRW	731.9 × 100M KRW	999.2 × 100M KRW	1,220.9 × 100M KRW	955.5 × 100M KRW	1,291.4 × 100M KRW	1,401.9 × 100M KRW
Operating profit	8.6 × 100M KRW	-107.8 × 100M KRW	-71.8 × 100M KRW	-152 × 100M KRW	-2.1 × 100M KRW	-121.2 × 100M KRW	-80.5 × 100M KRW	18.8 × 100M KRW	47.5 × 100M KRW	-27.3 × 100M KRW	-104.6 × 100M KRW	-68.3 × 100M KRW	-51.3 × 100M KRW
Net income	-19.7 × 100M KRW	-153.8 × 100M KRW	-119.8 × 100M KRW	-372.3 × 100M KRW	-71.6 × 100M KRW	-98.5 × 100M KRW	-372.9 × 100M KRW	10.6 × 100M KRW	84.3 × 100M KRW	-53.9 × 100M KRW	-379.4 × 100M KRW	-318.2 × 100M KRW	-21.8 × 100M KRW
Operating margin	2.82%	-52.01%	-40.47%	-154.90%	-1.08%	-111.80%	-44.91%	2.57%	4.75%	-2.23%	-10.94%	-5.29%	-3.66%
Balance sheet
Total assets	777.8 × 100M KRW	704 × 100M KRW	820 × 100M KRW	597 × 100M KRW	649.8 × 100M KRW	495.8 × 100M KRW	649.8 × 100M KRW	700.8 × 100M KRW	963.7 × 100M KRW	932.6 × 100M KRW	664.7 × 100M KRW	702.2 × 100M KRW	609.3 × 100M KRW
Total liabilities	285.7 × 100M KRW	263.9 × 100M KRW	407.3 × 100M KRW	252.4 × 100M KRW	304.6 × 100M KRW	265.6 × 100M KRW	492.6 × 100M KRW	306.4 × 100M KRW	473.2 × 100M KRW	381.3 × 100M KRW	434.5 × 100M KRW	611.6 × 100M KRW	525.4 × 100M KRW
Total equity	492 × 100M KRW	440.1 × 100M KRW	412.7 × 100M KRW	344.6 × 100M KRW	345.2 × 100M KRW	230.2 × 100M KRW	157.3 × 100M KRW	394.5 × 100M KRW	490.5 × 100M KRW	551.3 × 100M KRW	230.2 × 100M KRW	90.6 × 100M KRW	83.9 × 100M KRW
Cash flow statement
Operating cash flow	-	-	-	-	-	-	-	-	-	-	-	-4.2 × 100M KRW	-38.6 × 100M KRW
Investing cash flow	-	-	-	-	-	-	-	-	-	-	-	-43.8 × 100M KRW	-69 × 100M KRW
Financing cash flow	-	-	-	-	-	-	-	-	-	-	-	81.7 × 100M KRW	81.8 × 100M KRW
Investment indicators
ROE	-4.01%	-34.93%	-29.03%	-108.04%	-20.75%	-42.78%	-237.16%	2.69%	17.19%	-9.77%	-164.85%	-351.15%	-26.02%
Debt-to-equity ratio	58.07%	59.96%	98.70%	73.24%	88.24%	115.41%	313.22%	77.66%	96.46%	69.16%	188.78%	675.03%	625.94%
Separate total assets	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS	-	-	-	-	-	-	-	-	-	-	-	-	-
PER	-	-	-	-	-	-	-	-	-	-	-	-	-
PBR	-	-	-	-	-	-	-	-	-	-	-	-	-
Dividend per share	-	-	-	-	-	-	-	-	-	-	-	-	-
Detailed accounts
Current assets	-	-	368.6 × 100M KRW	-	-	228.3 × 100M KRW	-	-	733.6 × 100M KRW	-	-	522.9 × 100M KRW	453.6 × 100M KRW
Non-current assets	-	-	451.4 × 100M KRW	-	-	267.5 × 100M KRW	-	-	230.1 × 100M KRW	-	-	179.3 × 100M KRW	155.7 × 100M KRW
Current liabilities	-	-	390.2 × 100M KRW	-	-	223 × 100M KRW	-	-	428.2 × 100M KRW	-	-	584.2 × 100M KRW	505.6 × 100M KRW
Non-current liabilities	-	-	17.1 × 100M KRW	-	-	42.6 × 100M KRW	-	-	45 × 100M KRW	-	-	27.4 × 100M KRW	19.8 × 100M KRW
Equity attributable to owners	-	-	-	-	-	-	-	-	-	-	-	87.8 × 100M KRW	83.8 × 100M KRW
Share capital	-	-	775.8 × 100M KRW	-	-	102.1 × 100M KRW	-	-	198 × 100M KRW	-	-	257.6 × 100M KRW	274.8 × 100M KRW
Capital surplus	-	-	-	-	-	-	-	-	-	-	-	1,337.4 × 100M KRW	1,370.1 × 100M KRW
Retained earnings	-	-	-462.8 × 100M KRW	-	-	-234.7 × 100M KRW	-	-	-665.2 × 100M KRW	-	-	-1,411.3 × 100M KRW	-1,431.3 × 100M KRW
Non-controlling interests	-	-	-	-	-	-	-	-	-	-	-	2.8 × 100M KRW	1,206 × 10,000 KRW

ROE is net income divided by closing equity. PER and PBR are omitted when the accounting scope or price date is unverified.

셀루메드 — Quarterly Consolidated Financial statements
Item	24/3	24/6	24/9	24/12	25/3	25/6	25/9	25/12	26/3	26/6
Income statement
Revenue	262.7 × 100M KRW	329.5 × 100M KRW	332.8 × 100M KRW	366.3 × 100M KRW	392.5 × 100M KRW	353.7 × 100M KRW	372.9 × 100M KRW	282.8 × 100M KRW	234.2 × 100M KRW	308.1 × 100M KRW
Operating profit	-4.1 × 100M KRW	-17.4 × 100M KRW	-12.3 × 100M KRW	-34.5 × 100M KRW	-16.2 × 100M KRW	-43.1 × 100M KRW	14.5 × 100M KRW	-6.5 × 100M KRW	-15.8 × 100M KRW	15.6 × 100M KRW
Net income	-16.3 × 100M KRW	-27.2 × 100M KRW	-19.5 × 100M KRW	-255.1 × 100M KRW	-13.8 × 100M KRW	-25.3 × 100M KRW	79.9 × 100M KRW	-62.7 × 100M KRW	-17.1 × 100M KRW	26.3 × 100M KRW
Operating margin	-1.57%	-5.29%	-3.69%	-9.42%	-4.13%	-12.18%	3.89%	-2.30%	-6.73%	5.08%
Balance sheet
Total assets	749.8 × 100M KRW	792 × 100M KRW	759.3 × 100M KRW	702.2 × 100M KRW	750.4 × 100M KRW	745.1 × 100M KRW	716.2 × 100M KRW	609.3 × 100M KRW	685.3 × 100M KRW	721.1 × 100M KRW
Total liabilities	436 × 100M KRW	484 × 100M KRW	430.3 × 100M KRW	611.6 × 100M KRW	623.6 × 100M KRW	660.4 × 100M KRW	551 × 100M KRW	525.4 × 100M KRW	446.4 × 100M KRW	466.2 × 100M KRW
Total equity	313.8 × 100M KRW	308 × 100M KRW	329 × 100M KRW	90.6 × 100M KRW	126.8 × 100M KRW	84.7 × 100M KRW	165.2 × 100M KRW	83.9 × 100M KRW	238.9 × 100M KRW	254.8 × 100M KRW
Cash flow statement
Operating cash flow	19.3 × 100M KRW	-2.7 × 100M KRW	-34.3 × 100M KRW	13.6 × 100M KRW	-37.7 × 100M KRW	-14.2 × 100M KRW	-2.9 × 100M KRW	16.3 × 100M KRW	-62.8 × 100M KRW	12.9 × 100M KRW
Investing cash flow	-6.8 × 100M KRW	-37.7 × 100M KRW	-24 × 100M KRW	24.7 × 100M KRW	-21.4 × 100M KRW	-48.6 × 100M KRW	-2.3 × 100M KRW	3.4 × 100M KRW	8.2 × 100M KRW	-140.5 × 100M KRW
Financing cash flow	41 × 100M KRW	-12.6 × 100M KRW	38.5 × 100M KRW	14.7 × 100M KRW	32 × 100M KRW	50.2 × 100M KRW	-15.2 × 100M KRW	14.8 × 100M KRW	146.6 × 100M KRW	5.8 × 100M KRW
Investment indicators
Debt-to-equity ratio	138.95%	157.14%	130.78%	675.03%	491.72%	779.99%	333.50%	625.94%	186.87%	182.95%
EPS	-	-	-	-	-	-	-	-	-	-
Detailed accounts
Current assets	586.7 × 100M KRW	576.8 × 100M KRW	538.1 × 100M KRW	522.9 × 100M KRW	597.8 × 100M KRW	583.9 × 100M KRW	555 × 100M KRW	453.6 × 100M KRW	534.7 × 100M KRW	599.3 × 100M KRW
Non-current assets	163.1 × 100M KRW	215.2 × 100M KRW	221.2 × 100M KRW	179.3 × 100M KRW	152.6 × 100M KRW	161.2 × 100M KRW	161.3 × 100M KRW	155.7 × 100M KRW	150.6 × 100M KRW	121.7 × 100M KRW
Current liabilities	396 × 100M KRW	443.3 × 100M KRW	390.4 × 100M KRW	584.2 × 100M KRW	598.2 × 100M KRW	637.8 × 100M KRW	529.8 × 100M KRW	505.6 × 100M KRW	425.8 × 100M KRW	449.1 × 100M KRW
Non-current liabilities	40 × 100M KRW	40.7 × 100M KRW	39.9 × 100M KRW	27.4 × 100M KRW	25.3 × 100M KRW	22.7 × 100M KRW	21.2 × 100M KRW	19.8 × 100M KRW	20.6 × 100M KRW	17.1 × 100M KRW
Equity attributable to owners	308.3 × 100M KRW	302.7 × 100M KRW	323.6 × 100M KRW	87.8 × 100M KRW	123.1 × 100M KRW	82.9 × 100M KRW	163.1 × 100M KRW	83.8 × 100M KRW	238.9 × 100M KRW	254.7 × 100M KRW
Share capital	240.8 × 100M KRW	246.2 × 100M KRW	255.3 × 100M KRW	257.6 × 100M KRW	274.8 × 100M KRW	274.8 × 100M KRW	274.8 × 100M KRW	274.8 × 100M KRW	416 × 100M KRW	416.1 × 100M KRW
Capital surplus	1,274.8 × 100M KRW	1,290.8 × 100M KRW	1,322 × 100M KRW	1,337.4 × 100M KRW	1,370.1 × 100M KRW	1,370.1 × 100M KRW	1,370.1 × 100M KRW	1,370.1 × 100M KRW	1,399.1 × 100M KRW	1,399.5 × 100M KRW
Retained earnings	-1,111.1 × 100M KRW	-1,138.1 × 100M KRW	-1,157.6 × 100M KRW	-1,411.3 × 100M KRW	-1,426 × 100M KRW	-1,451.2 × 100M KRW	-1,371.7 × 100M KRW	-1,431.3 × 100M KRW	-1,448.1 × 100M KRW	-1,422.2 × 100M KRW
Non-controlling interests	5.5 × 100M KRW	5.3 × 100M KRW	5.4 × 100M KRW	2.8 × 100M KRW	3.7 × 100M KRW	1.7 × 100M KRW	2.1 × 100M KRW	1,206 × 10,000 KRW	-95 × 10,000 KRW	1,206 × 10,000 KRW

Income figures cover the quarter, not the year to date. Balance sheet figures are quarter-end balances.

Quarterly cash flow is calculated from changes in cumulative totals.

ROE is net income divided by closing equity. PER and PBR are omitted when the accounting scope or price date is unverified.

Separate · this company only

셀루메드 — Annual Separate Financial statements
Item	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Income statement
Revenue	282.4 × 100M KRW	186.3 × 100M KRW	163.5 × 100M KRW	100.4 × 100M KRW	192.8 × 100M KRW	99.3 × 100M KRW	128.4 × 100M KRW	165.4 × 100M KRW	197.8 × 100M KRW	273.6 × 100M KRW	151.5 × 100M KRW	111.7 × 100M KRW	120.4 × 100M KRW
Operating profit	16.7 × 100M KRW	-96.8 × 100M KRW	-57.5 × 100M KRW	-123.5 × 100M KRW	16.8 × 100M KRW	-118 × 100M KRW	-95.9 × 100M KRW	-16.7 × 100M KRW	18.6 × 100M KRW	-36 × 100M KRW	-67.8 × 100M KRW	-75.2 × 100M KRW	-61.6 × 100M KRW
Net income	-18.6 × 100M KRW	-217.2 × 100M KRW	-102.4 × 100M KRW	-354.3 × 100M KRW	-40 × 100M KRW	-127.2 × 100M KRW	-375.2 × 100M KRW	-16.8 × 100M KRW	37.7 × 100M KRW	-67 × 100M KRW	-284.8 × 100M KRW	-324.4 × 100M KRW	-68 × 100M KRW
Operating margin	5.91%	-51.96%	-35.14%	-123.00%	8.73%	-118.86%	-74.71%	-10.12%	9.41%	-13.16%	-44.80%	-67.31%	-51.17%
Balance sheet
Total assets	824.1 × 100M KRW	683.1 × 100M KRW	810.9 × 100M KRW	600.7 × 100M KRW	661.2 × 100M KRW	484.7 × 100M KRW	395 × 100M KRW	411.5 × 100M KRW	727.3 × 100M KRW	723.3 × 100M KRW	551.8 × 100M KRW	465.9 × 100M KRW	385.3 × 100M KRW
Total liabilities	279.7 × 100M KRW	255.5 × 100M KRW	395.3 × 100M KRW	238.5 × 100M KRW	267.1 × 100M KRW	231.4 × 100M KRW	353.2 × 100M KRW	160.1 × 100M KRW	272.5 × 100M KRW	217.7 × 100M KRW	271.7 × 100M KRW	331.3 × 100M KRW	263.2 × 100M KRW
Total equity	544.4 × 100M KRW	427.6 × 100M KRW	415.6 × 100M KRW	362.2 × 100M KRW	394.1 × 100M KRW	253.3 × 100M KRW	41.8 × 100M KRW	251.4 × 100M KRW	454.8 × 100M KRW	505.7 × 100M KRW	280.1 × 100M KRW	134.7 × 100M KRW	122.1 × 100M KRW
Cash flow statement
Operating cash flow	-	-	-	-	-	-	-	-	-	-	-	-42.2 × 100M KRW	-62.1 × 100M KRW
Investing cash flow	-	-	-	-	-	-	-	-	-	-	-	-36.4 × 100M KRW	-6.8 × 100M KRW
Financing cash flow	-	-	-	-	-	-	-	-	-	-	-	69.8 × 100M KRW	66.2 × 100M KRW
Investment indicators
ROE	-3.42%	-50.80%	-24.65%	-97.81%	-10.14%	-50.19%	-897.60%	-6.68%	8.30%	-13.26%	-101.67%	-240.89%	-55.73%
Debt-to-equity ratio	51.38%	59.75%	95.12%	65.84%	67.78%	91.32%	844.93%	63.71%	59.93%	43.05%	96.98%	246.02%	215.54%
Separate total assets	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS	-	-	-	-	-	-	-	-	-	-	-	-	-
PER	-	-	-	-	-	-	-	-	-	-	-	-	-
PBR	-	-	-	-	-	-	-	-	-	-	-	-	-
Dividend per share	-	-	-	-	-	-	-	-	-	-	-	-	-
Detailed accounts
Current assets	-	-	352.9 × 100M KRW	-	-	218.8 × 100M KRW	-	-	346.5 × 100M KRW	-	-	135.1 × 100M KRW	113.7 × 100M KRW
Non-current assets	-	-	458.1 × 100M KRW	-	-	265.9 × 100M KRW	-	-	380.8 × 100M KRW	-	-	330.8 × 100M KRW	271.6 × 100M KRW
Current liabilities	-	-	377.8 × 100M KRW	-	-	195.5 × 100M KRW	-	-	239.7 × 100M KRW	-	-	309.5 × 100M KRW	246.6 × 100M KRW
Non-current liabilities	-	-	17.5 × 100M KRW	-	-	35.9 × 100M KRW	-	-	32.8 × 100M KRW	-	-	21.8 × 100M KRW	16.5 × 100M KRW
Share capital	-	-	775.8 × 100M KRW	-	-	102.1 × 100M KRW	-	-	198 × 100M KRW	-	-	257.6 × 100M KRW	274.8 × 100M KRW
Capital surplus	-	-	-	-	-	-	-	-	-	-	-	1,348.6 × 100M KRW	1,381.2 × 100M KRW
Retained earnings	-	-	-476.1 × 100M KRW	-	-	-246.9 × 100M KRW	-	-	-704.4 × 100M KRW	-	-	-1,381.8 × 100M KRW	-1,446.9 × 100M KRW

ROE is net income divided by closing equity. PER and PBR are omitted when the accounting scope or price date is unverified.

셀루메드 — Quarterly Separate Financial statements
Item	24/3	24/6	24/9	24/12	25/3	25/6	25/9	25/12	26/3	26/6
Income statement
Revenue	-	-	-	-	-	-	-	-	19.3 × 100M KRW	20.3 × 100M KRW
Operating profit	-	-	-	-	-	-	-	-	-14.4 × 100M KRW	-16.2 × 100M KRW
Net income	-	-	-	-	-	-	-	-	-16.4 × 100M KRW	-24.4 × 100M KRW
Operating margin	-	-	-	-	-	-	-	-	-74.69%	-80.04%
Balance sheet
Total assets	-	-	-	-	-	-	-	-	515.2 × 100M KRW	487.6 × 100M KRW
Total liabilities	-	-	-	-	-	-	-	-	239.2 × 100M KRW	235.4 × 100M KRW
Total equity	-	-	-	-	-	-	-	-	276 × 100M KRW	252.2 × 100M KRW
Cash flow statement
Operating cash flow	-	-	-	-	-	-	-	-	-34 × 100M KRW	-2.8 × 100M KRW
Investing cash flow	-	-	-	-	-	-	-	-	6.5 × 100M KRW	-139.7 × 100M KRW
Financing cash flow	-	-	-	-	-	-	-	-	167.1 × 100M KRW	1.2 × 100M KRW
Investment indicators
Debt-to-equity ratio	-	-	-	-	-	-	-	-	86.64%	93.37%
EPS	-	-	-	-	-	-	-	-	-	-
Detailed accounts
Current assets	-	-	-	135.1 × 100M KRW	-	-	-	113.7 × 100M KRW	251 × 100M KRW	236.6 × 100M KRW
Non-current assets	-	-	-	330.8 × 100M KRW	-	-	-	271.6 × 100M KRW	264.2 × 100M KRW	251.1 × 100M KRW
Current liabilities	-	-	-	309.5 × 100M KRW	-	-	-	246.6 × 100M KRW	222.7 × 100M KRW	222.2 × 100M KRW
Non-current liabilities	-	-	-	21.8 × 100M KRW	-	-	-	16.5 × 100M KRW	16.4 × 100M KRW	13.2 × 100M KRW
Share capital	-	-	-	257.6 × 100M KRW	-	-	-	274.8 × 100M KRW	416 × 100M KRW	416.1 × 100M KRW
Capital surplus	-	-	-	1,348.6 × 100M KRW	-	-	-	1,381.2 × 100M KRW	1,410.3 × 100M KRW	1,410.6 × 100M KRW
Retained earnings	-	-	-	-1,381.8 × 100M KRW	-	-	-	-1,446.9 × 100M KRW	-1,463.3 × 100M KRW	-1,487.7 × 100M KRW

Income figures cover the quarter, not the year to date. Balance sheet figures are quarter-end balances.

Quarterly cash flow is calculated from changes in cumulative totals.

ROE is net income divided by closing equity. PER and PBR are omitted when the accounting scope or price date is unverified.

Legacy summaries and estimates; may include data with unverified accounting scope.

셀루메드 — Annual Legacy summary & estimates Financial statements
Item	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023 Consolidated	2024 Consolidated	2025 Consolidated
Income statement
Revenue	306.7 × 100M KRW	207.3 × 100M KRW	177.3 × 100M KRW	98.1 × 100M KRW	199 × 100M KRW	108.4 × 100M KRW	179.2 × 100M KRW	731.9 × 100M KRW	999.2 × 100M KRW	1,220.9 × 100M KRW	955.5 × 100M KRW	1,291.4 × 100M KRW	1,401.9 × 100M KRW
Operating profit	8.6 × 100M KRW	-107.8 × 100M KRW	-71.8 × 100M KRW	-152 × 100M KRW	-2.1 × 100M KRW	-121.2 × 100M KRW	-80.5 × 100M KRW	18.8 × 100M KRW	47.5 × 100M KRW	-27.3 × 100M KRW	-104.6 × 100M KRW	-68.3 × 100M KRW	-51.3 × 100M KRW
Net income	-19.7 × 100M KRW	-153.8 × 100M KRW	-119.8 × 100M KRW	-372.3 × 100M KRW	-71.6 × 100M KRW	-98.5 × 100M KRW	-372.9 × 100M KRW	10.6 × 100M KRW	84.3 × 100M KRW	-53.9 × 100M KRW	-379.4 × 100M KRW	-318.2 × 100M KRW	-21.8 × 100M KRW
Operating margin	2.82%	-52.01%	-40.47%	-154.90%	-1.08%	-111.80%	-44.91%	2.57%	4.75%	-2.23%	-10.94%	-5.29%	-3.66%
Balance sheet
Total assets	-	-	-	-	-	-	-	-	-	-	664.7 × 100M KRW	702.2 × 100M KRW	609.3 × 100M KRW
Total liabilities	285.7 × 100M KRW	263.9 × 100M KRW	407.3 × 100M KRW	252.4 × 100M KRW	304.6 × 100M KRW	265.6 × 100M KRW	492.6 × 100M KRW	306.4 × 100M KRW	473.2 × 100M KRW	381.3 × 100M KRW	434.5 × 100M KRW	611.6 × 100M KRW	525.4 × 100M KRW
Total equity	492 × 100M KRW	440.1 × 100M KRW	412.7 × 100M KRW	344.6 × 100M KRW	345.2 × 100M KRW	230.2 × 100M KRW	157.3 × 100M KRW	394.5 × 100M KRW	490.5 × 100M KRW	551.3 × 100M KRW	230.2 × 100M KRW	90.6 × 100M KRW	83.9 × 100M KRW
Investment indicators
ROE	-4.01%	-34.93%	-29.03%	-108.04%	-20.75%	-42.78%	-237.16%	2.69%	17.19%	-9.77%	-164.85%	-351.15%	-26.02%
Debt-to-equity ratio	58.07%	59.96%	98.70%	73.24%	88.24%	115.41%	313.22%	77.66%	96.46%	69.16%	188.78%	675.03%	625.94%
Separate total assets	-	-	-	-	-	-	-	-	-	-	551.8 × 100M KRW	465.9 × 100M KRW	385.3 × 100M KRW
EPS	-	-	-	-	-	-	-	-	-	KRW -139	KRW -876	KRW -648	KRW -41
PER	-	-	-	-	-	-	-	-	-	-31.48×	-2.45×	-3.92×	-27.98×
PBR	-	-	-	-	-	-	-	-	-	3.40	4.10	14.91	7.57
Dividend per share	-	-	-	-	-	-	-	-	-	-	-	-	-

셀루메드 — Quarterly Legacy summary & estimates Financial statements
Item	24/3 Consolidated	24/6 Consolidated	24/9 Consolidated	24/12 Consolidated	25/3 Consolidated	25/6 Consolidated	25/9 Consolidated	25/12 Consolidated	26/3 Consolidated	26/6 Consolidated
Income statement
Revenue	262.7 × 100M KRW	329.5 × 100M KRW	332.8 × 100M KRW	366.3 × 100M KRW	392.5 × 100M KRW	353.7 × 100M KRW	372.9 × 100M KRW	282.8 × 100M KRW	234.2 × 100M KRW	308.1 × 100M KRW
Operating profit	-4.1 × 100M KRW	-17.4 × 100M KRW	-12.3 × 100M KRW	-34.5 × 100M KRW	-16.2 × 100M KRW	-43.1 × 100M KRW	14.5 × 100M KRW	-6.5 × 100M KRW	-15.8 × 100M KRW	15.6 × 100M KRW
Net income	-16.3 × 100M KRW	-27.2 × 100M KRW	-19.5 × 100M KRW	-255.1 × 100M KRW	-13.8 × 100M KRW	-25.3 × 100M KRW	79.9 × 100M KRW	-62.7 × 100M KRW	-17.1 × 100M KRW	26.3 × 100M KRW
Operating margin	-1.57%	-5.29%	-3.69%	-9.42%	-4.13%	-12.18%	3.89%	-2.30%	-6.73%	5.08%
Balance sheet
Total assets	749.8 × 100M KRW	792 × 100M KRW	759.3 × 100M KRW	702.2 × 100M KRW	750.4 × 100M KRW	745.1 × 100M KRW	716.2 × 100M KRW	609.3 × 100M KRW	685.3 × 100M KRW	721.1 × 100M KRW
Total liabilities	436 × 100M KRW	484 × 100M KRW	430.3 × 100M KRW	611.6 × 100M KRW	623.6 × 100M KRW	660.4 × 100M KRW	551 × 100M KRW	525.4 × 100M KRW	446.4 × 100M KRW	466.2 × 100M KRW
Total equity	313.8 × 100M KRW	308 × 100M KRW	329 × 100M KRW	90.6 × 100M KRW	126.8 × 100M KRW	84.7 × 100M KRW	165.2 × 100M KRW	83.9 × 100M KRW	238.9 × 100M KRW	254.8 × 100M KRW
Investment indicators
Debt-to-equity ratio	138.95%	157.14%	130.78%	675.03%	491.72%	779.99%	333.50%	625.94%	186.87%	182.95%
EPS	-	-	-	-	-	-	-	-	-	-

Income figures cover the quarter, not the year to date. Balance sheet figures are quarter-end balances.

Property holdings

Property data is not available yet.

Ownership structure

Is a listed company shown as unlisted?

Corporate shareholders

Corporate and institutional holders identified in collected disclosures. This is not a complete shareholder register. Reporting-group holdings may overlap with individual holdings.

Articles of incorporation analysis

Analysis date 2026.07.30 16:25 | Last amended 2025.03.31

Unverified Original articles of incorporation

기타 주목 조항

분석 제한: 정관 원문이 제공되지 않아 사업보고서 힌트의 최근 개정일 외 조항을 확인할 수 없음

Board of directors

Number of directors

Director term

Staggered board

Cumulative voting

Separate chair and CEO

Gender diversity requirement

Shareholder meetings and dividends

Meeting notice period

Written voting

Electronic voting

Dividend record date

Executive compensation

Based on 2025 Annual report

Total compensation

5 × 100M KRW

Executives

5 people

Average per executive

1 × 100M KRW

Total dividends

Compensation / dividends

No dividend

Controlling shareholders

Name	Relationship	Age	Ownership
인스코비	Controlling shareholder	-	18.31%
프리텔레콤	최대주주 자회사	-	4.68%
구자갑	최대주주 대표이사	-	0.24%
김용회	최대주주 감사	-	0.14%
박민자	Related party	-	0.11%
유인수	CEO	-	0.02%

Holders of 5% or more

Holder	Holding ratio	Shares held	Change in ownership	Reason for filing	Report type	Filing date
상상인플러스저축은행	0.00%	0	0.00%	1. 채무자 기한이익상실에 따른 채권자의 담보처분권 취득 2. 담보처분권 행사 3. 채무자 기한이익회복에 따른 채권자의 담보처분권 해소 ※ 보고자는 채권자로서 담보처분권을 취득하였을 뿐 소유권을 취득한 것이 아님(고객계정 관련)	약식	2026-03-23
프리티	11.05%	9,191,031	-3.23%	- 특별관계자의 장내거래에 따른 변동 - 기한이익 상실에 따른 채권자의 담보처분권 취득 및 행사	일반	2026-03-19
인스코비	11.05%	9,191,031	-3.23%	- 특별관계자의 장내거래에 따른 변동 - 기한이익 상실에 따른 채권자의 담보처분권 취득 및 행사	일반	2026-03-19
프리티	14.28%	11,877,036	-9.26%	특별관계자의 장내거래에 따른 변동	일반	2026-02-13
인스코비	14.28%	11,877,036	-9.26%	특별관계자의 장내거래에 따른 변동	일반	2026-02-13
티디랜드마크조합1호	33.91%	28,192,370	+33.91%	유상 신주취득	일반	2026-01-28
프리티	23.54%	12,933,790	+0.08%	특별관계자의 장내거래에 따른 변동	일반	2025-09-30
인스코비	23.54%	12,933,790	+0.08%	특별관계자의 장내거래에 따른 변동	일반	2025-09-30
프리티	23.46%	12,891,790	-6.73%	기한이익 상실에 따른 채권자의 담보처분권 취득 및 행사	일반	2025-08-26
인스코비	23.46%	12,891,790	-6.73%	기한이익 상실에 따른 채권자의 담보처분권 취득 및 행사	일반	2025-08-26
상상인저축은행	2.29%	1,260,152	+2.29%	채무자 기한이익 상실에 따른 채권자의 담보처분권 취득 및 담보처분권 행사 ※ 보고자 및 특별관계자는 채권자로서 담보처분권을 취득하였을 뿐 소유권을 취득한 것이 아님	약식	2025-08-25
프리티	30.19%	16,590,231	-0.03%	특별관계자의 장내거래에 따른 변동	일반	2025-04-22
인스코비	30.19%	16,590,231	-0.03%	특별관계자의 장내거래에 따른 변동	일반	2025-04-22
프리티	30.22%	16,607,231	+4.66%	제3자배정 유상증자 완료에 따른 변동	일반	2025-04-01
인스코비	30.22%	16,607,231	+4.66%	제3자배정 유상증자 완료에 따른 변동	일반	2025-04-01
프리티	25.56%	13,166,074	-1.94%	특별관계자의 장내매도로 인한 변동	일반	2025-02-14
인스코비	25.56%	13,166,074	-1.94%	특별관계자의 장내매도로 인한 변동	일반	2025-02-14
프리티	27.50%	14,166,074	0.00%	주식담보대출 계약 만기연장에 따른 변경	일반	2025-02-07
인스코비	27.50%	14,166,074	0.00%	주식담보대출 계약 만기연장에 따른 변경	일반	2025-02-07
프리티	27.50%	14,166,074	-0.64%	주식담보대출 계약 만기연장에 따른 변경	일반	2024-11-05
인스코비	27.50%	14,166,074	-0.64%	주식담보대출 계약 만기연장에 따른 변경	일반	2024-11-05
프리티	28.14%	14,166,074	-0.57%	특별관계자의 장내매수	일반	2024-10-08
인스코비	28.14%	14,166,074	-0.57%	특별관계자의 장내매수	일반	2024-10-08
프리티	28.71%	14,136,074	0.00%	주식담보대출 계약 체결에 따른 변경	일반	2024-08-05
인스코비	28.71%	14,136,074	0.00%	주식담보대출 계약 체결에 따른 변경	일반	2024-08-05
프리티	28.71%	14,136,074	-0.98%	특별관계자의 장내매도로 인한 변동	일반	2024-08-01
인스코비	28.71%	14,136,074	-0.98%	특별관계자의 장내매도로 인한 변동	일반	2024-08-01
인스코비	29.69%	14,616,074	+8.06%	제3자배정 유상증자에 의한 추가 취득	일반	2024-06-11
상상인저축은행	0.00%	0	-5.15%	전환사채 조기상환에 따른 변동 보고의무 발생	약식	2024-04-11
상상인저축은행	5.15%	2,327,108	+5.15%	전환가액 조정에 따른 신규 보고의무(5%) 발생	약식	2024-03-08

Auditors

Analysis date 2026.10.15 23:00

Auditor	Type	Term start	Term end	Tenure	D-day
강판헌	Auditor	2022.03.29	2025.03.29	4 years	Expired
유준영	Auditor	2024.03.29	2027.03.29	2 years	D-145
김기호	Auditor	2025.03.31	2028.03.31	1 years	D-513

Executives

Name	Position	Category	Age	Term end
김기호	감사	감사	Age 74	D-513
박형섭	사외이사	Outside director	Age 66	Expired
유인수	대표이사	Inside director	Age 64	D-145
박찬웅	전무	Inside director	Age 58	D-145
김홍로	전무	미등기	Age 57	-
김병배	전무	미등기	Age 54	-
유준영	상무	Inside director	Age 40	D-145

DART disclosures

Loading disclosures…

셀루메드 KOSDAQ

Meeting voting results Collapse Meeting voting results

Financial indicators Collapse Financial indicators

Share price history 10 years 5 years 3 years 1 year 3 months 1 week Collapse Share price history

Shareholder distribution Collapse Shareholder distribution

Annual earnings Trend Collapse Annual earnings

Financial statements Collapse Financial statements

Consolidated

Separate

Legacy summary & estimates

Property holdings Collapse Property holdings

Ownership structure Collapse Ownership structure

Corporate shareholders Collapse Corporate shareholders

Articles of incorporation analysis Collapse Articles of incorporation analysis

기타 주목 조항

Board of directors

Shareholder meetings and dividends

Executive compensation Collapse Executive compensation

Controlling shareholders Collapse Controlling shareholders

Holders of 5% or more Collapse Holders of 5% or more

Auditors Collapse Auditors

Executives Collapse Executives

DART disclosures Collapse DART disclosures

Meeting voting results

Financial indicators

Share price history

Shareholder distribution

Annual earnings Trend

Financial statements

Property holdings

Ownership structure

Corporate shareholders

Articles of incorporation analysis

Executive compensation

Controlling shareholders

Holders of 5% or more

Auditors

Executives

DART disclosures